Key result
Thiazide diuretics reduce BP, morbidity, and mortality in essential hypertension with minimal metabolic side effects.
Answers are grounded in this paper and cite their sources.
Reveals thiazide diuretics effectively lower blood pressure and mortality with minimal metabolic risks, indicating they remain an ideal first-line treatment for hypertension.
Thiazide diuretics are efficacious, either as monotherapy or in combination with other antihypertensive drugs. They reduce blood pressure in a high percentage of hypertensive patients with minimal subjective side effects. There is increasing evidence that the use of diuretics, singly or in combination, will reduce morbidity and mortality associated with essential hypertension in both young and elderly subjects. Although diuretics may induce some changes in the plasma lipid profile, serum uric acid concentration and glucose metabolism, there is little evidence that these changes are of clinical significance. The increase in serum cholesterol concentration has rarely persisted in any trial beyond the first year of treatment. The incidence of diabetes mellitus in diuretic treated subjects is only about 1%, even when large doses are used. Gout may be precipitated in susceptible subjects, but is uncommon. For these reasons, diuretics should remain a preferred first-step drug of choice in the management of hypertension.
No takes yet. Share an insight, caveat, or question.
M. Moser (1992) conducted a review in Essential hypertension. Thiazide diuretics was evaluated. Thiazide diuretics effectively reduce blood pressure, morbidity, and mortality in essential hypertension with minimal clinically significant metabolic side effects.
Synapse has enriched 10 related papers. Consider them for comparative context: